Sodium thiosulfate in the treatment of calcific uremic arteriolopathy
暂无分享,去创建一个
[1] M. McAleer,et al. Calciphylaxis in a patient with normal renal function: response to treatment with sodium thiosulfate , 2009, Clinical and experimental dermatology.
[2] F. Frey,et al. Sodium thiosulfate prevents vascular calcifications in uremic rats. , 2008, Kidney international.
[3] M. Panda,et al. Non-healing painful ulcers in a patient with chronic kidney disease and role of sodium thiosulfate: a case report , 2008, Cases journal.
[4] C. Musso,et al. Oral sodium thiosulfate solution as a secondary preventive treatment for calciphylaxis in dialysis patients. , 2008, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
[5] C. Raymond,et al. Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. , 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[6] I. Griveas,et al. Combination of Sodium Thiosulphate, Cinacalcet, and Paricalcitol in the Treatment of Calciphylaxis with Hyperparathyroidism , 2008, The International journal of artificial organs.
[7] W. Leslie,et al. Bone scan findings in metastatic calcification from calciphylaxis. , 2008, Clinical nuclear medicine.
[8] M. Wolf,et al. Calciphylaxis from nonuremic causes: a systematic review. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[9] A. Fine,et al. Calciphylaxis: The Beginning of the End? , 2008, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[10] K. Subramaniam,et al. Degos' disease with delayed involvement of the gastrointestinal tract , 2008, The Australasian journal of dermatology.
[11] L. Schurgers,et al. The Circulating Inactive Form of Matrix Gla Protein (ucMGP) as a Biomarker for Cardiovascular Calcification , 2008, Journal of Vascular Research.
[12] J. Sowers,et al. Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate , 2008, International Urology and Nephrology.
[13] R. Weenig. Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. , 2008, Journal of the American Academy of Dermatology.
[14] K. Subramaniam,et al. Complete resolution of recurrent calciphylaxis with long‐term intravenous sodium thiosulfate , 2008, The Australasian journal of dermatology.
[15] C. Lebbé,et al. Sodium thiosulfate as first-line treatment for calciphylaxis. , 2007, Archives of dermatology.
[16] William Huen,et al. Calciphylaxis with Arterial Calcification , 2007 .
[17] P. Coates,et al. VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: Calcific Uremic Arteriolopathy: Advances in Pathogenesis and Treatment , 2007 .
[18] R. Westenfeld,et al. VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: Inhibitors of Calcification in Blood and Urine , 2007 .
[19] L. Buescher,et al. Calciphylaxis responding to sodium thiosulfate therapy. , 2007, Archives of dermatology.
[20] R. Fennell,et al. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[21] M. Meissner,et al. Sodium Thiosulphate as a Promising Therapeutic Option to Treat Calciphylaxis , 2006, Dermatology.
[22] B. Bastani,et al. Intraperitoneal Sodium Thiosulfate for the Treatment of Calciphylaxis , 2006, Renal failure.
[23] D. Serur,et al. Dialysis Rounds A Dialysis Case Presentation and Discussion Edited by Roger A. Rodby : Long‐Term Intravenous Sodium Thiosulfate in the Treatment of a Patient with Calciphylaxis , 2005, Seminars in dialysis.
[24] G. Guerra,et al. Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[25] Lisa Kolb,et al. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. , 2005, Cardiovascular diabetology.
[26] D. Spector,et al. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] G. Greloni,et al. Cutaneous necrosis by calcific uremic arteriolopathy , 2004, International journal of dermatology.
[28] A. Schwarz,et al. The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification , 2003 .
[29] R. Crawford,et al. Three-dimensional analysis of a calciphylaxis plaque: clues to pathogenesis. , 2002, Journal of the American Academy of Dermatology.
[30] D. Riegert-Johnson,et al. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K. , 2001, Mayo Clinic proceedings.
[31] S. Myers,et al. Calciphylaxis in patients on hemodialysis: a prevalence study. , 1997, Surgery.
[32] A. Fischer,et al. Pathogenesis of calciphylaxis: study of three cases with literature review. , 1995, Human pathology.
[33] William Huen,et al. Images in clinical medicine. Calciphylaxis with arterial calcification. , 2007, The New England journal of medicine.
[34] M. Hayden,et al. Calciphylaxis and the cardiometabolic syndrome. , 2006, Journal of the cardiometabolic syndrome.